How a Drug Company Made $114 Billion by Gaming the U.S. Patent System
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.
Source: nytimes.com
Stay updated with breaking news from Barb Teron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AbbVie for years delayed competition for its blockbuster drug Humira, at the expense of patients and taxpayers. The monopoly is about to end.